• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Marketplace
  • Events
  • Education
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Government action required to mitigate medicine shortages

4th November 2020 by PIP editor Leave a Comment

 

The National Pharmacy Association (NPA) has written to the minister for the Cabinet Office Michael Gove, to express concerns over the impact of the Brexit Withdrawal Agreement and the Northern Ireland protocol on the medicines supply chain.

 

In a letter sent to Mr Gove on 27th October, NPA chair Andrew Lane said the requirement for Northern Ireland to continue to comply with EU medicines regulations that will no longer apply in the UK (which is the main source of supply) would distort the medicines supply chain.

 

He warns that the additional cost and complexity of getting medicines into Northern Ireland could result in some manufacturers not bringing products to the market. This in turn could lead to medicines shortages and an increase in procurement costs.

 

Without a clear plan on a transition from the UK-wide system into one that serves only Northern Ireland, it is likely that manufacturers of medicines, particularly generic medicines, will simply stop producing packs that meet the requirements for supply in Northern Ireland, Mr Lane predicts in his letter.

 

The NPA is urging the UK government to apply robust mitigation to the medicines supply chain from 31st December 2020 for a period of at least 18 months, to allow the supply chain to adapt to Brexit-related changes.

 

Earlier this month, the UK Community Pharmacy Falsified Medicine Directive Working Group called on the government in Westminster to protect the supply of medicines into Northern Ireland following the end of the Brexit transition period.  The working group consists of the national organisations representing community pharmacy across the UK (NPA, CCA, AIM, PSNC, CPS, CPW, CPNI).

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  You are the future, Scotland's CPO tells CLIP participants

Filed Under: News Tagged With: Medicine shortages

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Stay connected with us

  • E-mail
  • Facebook
  • Instagram
  • LinkedIn
  • Phone
  • Twitter

Your Pharmacy in Practice Prescription

Categories

Pharmacy in Practice member login

 
 
Forgot Password

Register for our upcoming live Q&A

https://www.youtube.com/watch?v=vVNhKJWCGFA

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.